Skip to Main Content

Paper Details

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol
0
2023
III NSCLC, NSCLC, circulating tumor DNA, ctDNA, non-small cell lung cancer, patient, patients, single nucleotide variants, stage I-III, tumor
Author NameAffiliation
Minetta C LiuInc.
Charles M RudinMemorial Sloan Kettering Cancer Center
Charles M RudinCornell University
Daniel R GomezMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2